Absci Corporation (ABSI) Financials

ABSI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 195.6 million 23.6 million
Dec. 31, 2025 216.3 million 26.8 million
Sept. 30, 2025 245.0 million 34.7 million
June 30, 2025 209.9 million 36.5 million

ABSI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -26.3 million 4.4 million
Dec. 31, 2025 -29.1 million 4.3 million
Sept. 30, 2025 -26.0 million 4.4 million
June 30, 2025 -17.1 million 4.8 million

ABSI Net Income

No data available :(

ABSI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 125.7 million - 2.1 million
Dec. 31, 2025 144.3 million - 2.6 million
Sept. 30, 2025 152.5 million 65000 4.8 million
June 30, 2025 117.5 million 161000 5.3 million

ABSI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 153.0 million
Dec. 31, 2025 150.6 million
Sept. 30, 2025 143.8 million
June 30, 2025 127.6 million

ABSI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 30000 19.3 million 9.1 million -
Dec. 31, 2025 103000 25.3 million 8.6 million -
Sept. 30, 2025 962000 19.2 million 8.4 million -
June 30, 2025 223000 20.5 million 8.5 million -

ABSI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 215000 2.7 million
Dec. 31, 2025 650000 2.8 million
Sept. 30, 2025 378000 -
June 30, 2025 593000 20.5 million

ABSI

Price: $7.56

52 week price:
2.24
12.06

Earnings Per Share: -0.82 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 382100

Market Capitalization: 2.0 billion

Links: